Bone-targeted therapy in metastatic breast cancer - all well-established knowledge?

Gampenrieder, Simon P; Rinnerthaler, Gabriel; Greil, Richard

Gampenrieder, Simon P; Rinnerthaler, Gabriel; Greil, Richard.

Afiliação

Gampenrieder SP; III Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute (SCRI) with Laboratory of Immunological and Molecular Cancer Research (LIMCR) and Center for Clinical Cancer and Immunology Trials (CCCIT), Paracelsus Medical University Salzburg, Salzburg, Austria.
Rinnerthaler G; III Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute (SCRI) with Laboratory of Immunological and Molecular Cancer Research (LIMCR) and Center for Clinical Cancer and Immunology Trials (CCCIT), Paracelsus Medical University Salzburg, Salzburg, Austria.
Greil R; III Medical Department with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute (SCRI) with Laboratory of Immunological and Molecular Cancer Research (LIMCR) and Center for Clinical Cancer and Immunology Trials (CCCIT), Paracelsus Medical University Salzburg, Salzburg, Austria.

Breast Care (Basel) ; 9(5): 323-30, 2014 Oct.

Article em En | MEDLINE | ID: mdl-25759612

Palavras-chave

Bisphosphonates; Bone metastasis; Bone-targeted therapy; Denosumab; Metastatic breast cancer

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Breast Care (Basel) Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Áustria País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google